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Single-cell RNA sequencing of cells from cultured human blasto-
cysts has enabled us to define the transcriptomic landscape of
placental trophoblast (TB) that surrounds the epiblast and associ-
ated embryonic tissues during the enigmatic day 8 (D8) to D12
peri-implantation period before the villous placenta forms. We
analyzed the transcriptomes of 3 early placental cell types, cytoTB
(CTB), syncytioTB (STB), and migratoryTB (MTB), picked manually
from cultured embryos dissociated with trypsin and were able to
follow sublineages that emerged from proliferating CTB at the
periphery of the conceptus. A unique form of CTB with some
features of STB was detectable at D8, while mature STB was at its
zenith at D10. A form of MTB with a mixed MTB/CTB phenotype
arose around D10. By D12, STB generation was in decline, CTB had
entered a new phase of proliferation, and mature MTB cells had
begun to move from the main body of the conceptus. Notably, the
MTB transcriptome at D12 indicated enrichment of transcripts
associated with IFN signaling, migration, and invasion and up-
regulation of HLA-C, HLA-E, and HLA-G. The STB, which is distinct
from the STB of later villous STB, had a phenotype consistent with
intense protein export and placental hormone production, as well
as migration and invasion. The studies show that TB associated
with human embryos is in rapid developmental flux during peri-
implantation period when it must invade, signal robustly to the
mother to ensure that the pregnancy continues, and make first
contact with the maternal immune system.
single-cell RNA sequencing | transcriptome | interferon | human
endogenous retroviruses
Implantation of the human embryo into the uterine wall is poorlyunderstood and not closely paralleled in model organisms, such
as the mouse. It is estimated that 40 to 60% of human conceptions
fail, with the majority of the losses occurring just prior to or during
implantation (1, 2), a process that is initiated soon after the
blastocyst attaches to the uterine wall at about day 6 (D6) post-
conception. What little is known of early human embryo devel-
opment and emergence of the earliest form of the placenta (3, 4)
has come from histological studies performed more than 50 y ago
(5–7), archived material (8), and parallels with nonhuman pri-
mates (8–10). The generally accepted view is that soon after the
polar trophectoderm of the D6 to D7 blastocyst adheres to the
uterine wall, a zone of invasive syncytiotrophoblast (STB) forms at
the implantation site where it locally displaces uterine epithelial
cells, thereby allowing the conceptus to penetrate the underlying
stroma. The STB soon surrounds the conceptus and, as it advances
into the decidualized endometrium, hollows out lacunae, which
become filled with blood and uterine secretions that likely pro-
vision the conceptus (11–14). The trophoblasts of this tiny con-
ceptus must also release sufficient human chorionic gonadotropin
(hCG) to rescue the corpus luteum; otherwise, the pregnancy fails.
By D12, columns of cytotrophoblast (CTB) begin to penetrate the
STB to form primary villi, which will eventually branch, acquire
cores of blood vessels and connective tissue, and form the
emerging villous placenta, while the fate of the original STB layer
remains unclear. All these events occur prior to the time that a new
menstrual cycle would normally begin in a nonpregnant woman.
The above histological studies have only provided a glimpse of
events that occur during the second week of pregnancy and have
been unable to provide insights into the dynamic process of
implantation and what can go wrong. Some models for under-
standing placental trophoblast emergence have shown promise.
For example, human pluripotent stem cells exposed to BMP4
can be driven efficiently to what has been proposed to be tro-
phoblast analogous to that encountered around the periphery of
an implanting conceptus (15, 16). Trophoblast stem cells derived
from either preimplantation blastocysts or first trimester villi
(17) and from trophoblast organoids (18, 19) also can be induced
to differentiate along trophoblast sublineages. Recently, a system
has been described that allows human embryos to be cultured
in vitro for up to 14 d (20, 21). Here we have used such a system
to compare trophoblast lineages from embryos at increasing days
in culture, primarily through use of single-cell RNA sequencing
(RNA-seq) to gain insights into events driving early placental
emergence. It should be noted that there have been 3 previous
papers that explored the nature of trophoblast in cultured human
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embryos by using the single-cell RNA-seq approach (22–24), but
these studies were confined to the preimplantation period.
Results
Embryo Extended Culture and Single-Cell Collection. Vitrified and
warmed D5 donated human blastocysts were cultured to embry-
onic D8, D10, and D12 according to a published protocol (20, 21)
(Fig. 1 A and B and SI Appendix, Table S1). By D8, most embryos
attached to the bottom of the dish and possessed a peripherally
located, apparently syncytial region that was positive for CG
subunit beta (CGB) (Fig. 1C), a definitive STB marker, and had
initiated secretion of hCG into the medium (Fig. 1D). Syncytial
areas expanded over time and stained more intensely for CGB at
D10 and D12 than at D8 (Fig. 1C and SI Appendix, Fig. S1A).
Daily release of hCG increased 41-fold by D10 compared to D8
(Fig. 1D). The expression of epiblast marker, POU5F1, was con-
fined to a central area that represents the formation of the em-
bryonic disk (SI Appendix, Fig. S1 A and B). The commonly used
trophoblast markers, KRT7 and GATA3, were also confirmed in
these outer regions by immunofluorescence staining (SI Appendix,
Fig. S1B). In some D10 cultures, it was possible to observe a few
cells migrating away from the embryo. By D12, these migrating
cells had become more numerous. A time-lapse video that fol-
lowed development between D8 and D12 was consistent with
these patterns of cell fusion and migration during extended culture
(Movie S1).
Finally, after treating D8, D10, and D12 embryos with trypsin,
3 different classes of placental cells were selected and individu-
ally picked, based on their size and location, for RNA-seq. The
smallest, round cells (Fig. 1E) were inferred to be mononucle-
ated CTB and possibly also similarly sized cells from other
lineages. The multinucleated STB (SI Appendix, Fig. S1A) were
easily identified as irregular shaped structures significantly larger
than the small cells (Fig. 1E). The migratory trophoblast cells
(MTB) recognized as seemingly moving away from the main
body of the embryo were collected before the embryos had been
fully dissociated by the trypsin (Fig. 1 B and E). Although we
were able to pick populations of CTB and STB at D8, D10, and
D12, MTB cells were solely from D12 because of their scarcity
at earlier times (Fig. 1 A and B). RNA was extracted from 139
samples derived from 11 embryos (SI Appendix, Table S2) and,
upon sequencing, generated ∼1.4 billion reads (∼10 million reads
per individual cell). To ensure we were only analyzing the tran-
scriptomes of trophoblast cells and not other cell types, cell line-
ages were first predicted based on reported expression of lineage
markers derived from human blastocysts (24) by Spearman cor-
relation algorithm. Initially, 7 single-cell samples were considered
to be nontrophoblast by these criteria. However, when additional
known lineage marker genes (POU5F1, GATA6, KRT7, GATA3,
SOX2, NANOG, and CD24) (20) were used to check these 7 cells,
5 were considered to be trophoblast because of their high ex-
pression of KRT7 and GATA3. The remaining 2 were confirmed
as epiblast (high expression of POU5F1, SOX2, and NANOG and
low in KRT7 and GATA3) and were excluded from the extended
analysis (SI Appendix, Table S3). Principal component analysis
(PCA) and clustering analyses identified 9 cells as outliers, while 3
cells had low read counts (<8,000 genes detected). These were
also discarded. In the final analysis of the remaining 125 cells (78
CTB, 31 STB, and 16 MTB), there were 14,105 genes with a
maximum FPKM ≥ 1 and 15,420 genes with a maximum FPKM ≥
0.3 in at least 4 cells (SI Appendix, Fig. S2A). These genes
remained in the analysis, while all others were excluded. In gen-
eral, the CTB expressed the highest number of expressed genes
per cell, but there was no significant difference in number within
any grouping between D8, D10, and D12 (SI Appendix, Fig. S2B).
Cell Type Specific Marker Expression and Pathway Analysis. PCA was
performed to show transcriptional profiles of all 3 cell populations
at the different collection time points (Fig. 2A). The transcriptomic
profiles clustered better according to cell type (CTB, STB, and
MTB) than by day, i.e., developmental stage (SI Appendix, Fig. S3
A and B). Unsupervised clustering analysis (K-means) further
revealed 17 small cells (CTB) had a partial MTB signature and
were classified as Pre-MTB, while 15 small cells had a partial
STB signature and were designated Pre-STB (Fig. 2B). We infer
Fig. 1. Isolation of single cells from extended cultured human embryos. (A)
Workflow for culturing human embryos and isolating cytotrophoblast (CTB),
syncytiotrophoblast (STB), and migratory trophoblast (MTB) for single-cell
RNA-seq. (B) Morphologies of a D5 human blastocyst after zona pellucida
removal and embryos at embryonic D8, D10, and D12. Pink circles outline
MTB seen at D12 but rarely earlier. (Scale bar, 200 μm.) (C) Beta-human CG
(CGB) immunofluorescence at embryonic D8, D10, and D12 (n = 3). (Scale
bar, 200 μm.) (D) Levels of hCG in cell culture medium at embryonic D8 to
D12 (mean ± SEM) (n = 13). (E) Morphologies of CTB, STB, and MTB after
single-cell enzyme digestion. (Scale bar, 200 μm.)



































Fig. 2. Identification of cell type specific markers for CTB, STB, and MTB. (A) PCA of trophoblast cells showing discrete clusters based on cell type. (B) PCA
analysis reveals subsets of CTB that had partial STB and MTB signatures, classified as Pre-STB and Pre-MTB, respectively. (C) Average FPKM for CTB, STB, and
MTB marker gene expression in each cell type. (D) Expression, based on least likelihood of false discovery of the top 10 marker genes for CTB, STB, and MTB in
each cell type. (E) Hierarchical clustering analysis of cell type marker genes in trophoblast cells. These 3 panels of marker genes clearly partitioned each major
TE cell type. Three panels of marker genes specifically for CTB, STB, and MTB are presented in the y axis, and cell types with different developmental stages
are presented in the x axis. The color spectrum, ranging from yellow to black, indicates high to low normalized levels of gene expression. (F) Spearman
correlation map indicating strong correlations between each cell type and their marker genes. The color spectrum, ranging from red to blue, indicates the
correlation from high to low.
















































that these intermediate-stage cells were in the process of dif-
ferentiating from CTB to either the MTB or STB sublineages.
Cells considered to be in these 2 intermediate classes were re-
moved from the remainder of the CTB group in order to identify
the unique transcriptome signature for CTB. We also identified
genes that were enriched in each cell type. Specifically, 2932,
592, and 569 genes were identified as enriched marker genes for
CTB, STB, and MTB, respectively (Fig. 2 C and D and Dataset
S1). Based on such gene panels, each main cell type could be
clearly separated by hierarchical clustering analysis (Fig. 2E),
which indicated strong correlations to their corresponding cell
type specific genes (Fig. 2F) and demonstrated the robustness of
each panel to identify each respective cell lineage.
Next, gene ontology (GO) and pathway analysis was per-
formed to identify pathways most strongly associated with each
cell type. The top GO terms for CTB were ones linked to cell
proliferation, transcription, and energy metabolism (SI Appendix,
Fig. S4), consistent with the inferred role of CTB in supplying
cells to the other trophoblast lineages and ultimately the placenta
as a whole. For STB, the top terms were protein folding, transport,
and hormone processing (SI Appendix, Fig. S4), which are again
consistent with known functions of syncytial trophoblast, whether
in the villous placenta or the primitive placenta encountered in
very early pregnancy (16). Pathways involved in protein export and
uptake, steroidogenesis, and migration were also up-regulated.
The latter term may reflect the suspected invasive as well as en-
docrine nature of early STB during the implantation phase of
pregnancy (25). As anticipated, MTB-enriched pathways under-
scored roles in cell migration and invasion into the extracellular
matrix. More surprising was the presence of terms and pathways
associated with type I and type II IFN signaling, innate immune
responses, and antigen processing (SI Appendix, Fig. S4).
Dynamics of Trophoblast Differentiation. While the transcriptomic
profiles of the STB remained relatively stable between D8 and
D12, those of the CTB showed considerable change, possibly
reflecting the developmental plasticity of the CTB as the cells
prepare for differentiation (Fig. 3 A and B). A comparison of the
transcriptomes of CTB between D8 and D10, for example,
reflected a switch from a proliferative phenotype at D8 to one with
a greater emphasis on syncytialization, protein processing, and
steroidogenesis at D10, suggesting that differentiation toward STB
had become an emphasis. Additionally, several MTB-related GO
pathways, including angiogenesis, response to hypoxia, and re-
sponse to cytokines and hormones, had also become active at D10
(Fig. 3D and SI Appendix, Fig. S5). These data suggest that there
are 2 distinct differentiation routes ongoing for CTB at D10, one
to STB and the other to MTB. This inference is supported by the
fact that the majority of small cells collected at D10 were either
Pre-STB (12 out of 23) or Pre-MTB (6 out of 23), and only 5
(21.7%) possessed the phenotype of bona fide undifferentiated
CTB (Fig. 3C). By D12, there was evidence of a more emphatic
shift toward a Pre-MTB phenotype, as evidenced by an up-
regulation of pathways related to IFN signaling, hypoxia, cell mi-
gration, and vascular remodeling, while genes associated with
syncytium formation had become less dominant than in D10 CTB
(Fig. 3D and SI Appendix, Fig. S5). Additionally, more Pre-MTB
(10 out of 30 small cells) and fewer Pre-STB (2 out of 30 small
cells) were present in the population of CTB collected at D12 (Fig.
3C). There also appeared to be a partial restoration of undiffer-
entiated CTB numbers at D12, as well as the appearance of a
possible new phenotype in the form of 2 cells with a mixed STB/
MTB signature (Fig. 3C).
We then compared the transcriptomes of Pre-STB and Pre-
MTB, with undifferentiated CTB and differentiated STB and MTB
regardless of their collection day. While Pre-STB had up-regulated
genes associated with syncytium formation (Fig. 3E and SI Ap-
pendix, Fig. S6A), they also had retained high mitotic activity as
suggested by their expression levels of the cell proliferation
markers PCNA and MCM genes (26, 27) (SI Appendix, Fig. S7).
By contrast, the differentiated STB showed evidence for depar-
ture from the cell cycle and possessed gene networks linked
to protein transport and hormone production that were largely
absent from Pre-STB (Fig. 3E and SI Appendix, Fig. S6A). We
conclude that the Pre-STB represent a population of dividing
CTB primed to fuse to form syncytium but that had not yet up-
regulated the machinery required for hormone production and
cell fusion (Fig. 3E and SI Appendix, Fig. S6A). The Pre-MTB
existed in an analogous state to the Pre-STB, i.e., committed to
differentiation but lacking the full-blown phenotype of MTB. For
example, they appeared to be continuing to proliferate, although
the pathways related to RNA processing had begun to decline
(Fig. 3E and SI Appendix, Fig. S6B). GO terms related to IFN
signaling and antigen processing that had been strongly repre-
sented in mature MTB had apparently not been acquired by the
Pre-MTB.
Gene Networks Linked to IFN Responses. Closer analysis of the
RNA-seq data revealed that several IFN response genes were
expressed as early as D8 in trophoblast cells and increased in
expression as development proceeded (Fig. 4A). GO pathway
analysis indicated that D12 CTB (SI Appendix, Fig. S5) and MTB
(SI Appendix, Fig. S4) had several terms associated with type I
and type II IFN signaling pathways. To confirm these findings,
we immunostained embryos for type I IFN receptor subunits
1 (IFNAR1), type II IFN receptor subunit 2 (IFNGR2), and
ISG20 (Fig. 4B). We found expression of INFAR1 and ISG20 as
early as D8, with IFNAR1 and ISG20 mainly located to the
periphery of the colonies where differentiation occurs (Fig. 4B).
All of the IFN-related markers became positive by D12. The
increase in expression of IFNAR2 and ISG15 were also confirmed
by Western blotting (Fig. 4C).
An IFN response triggered by type I and type II IFN is me-
diated by the JAK-STAT pathway (28). Although total STAT1
increased over time, we found no evidence for the presence of its
phosphorylated form, indicating the JAK-STAT pathway was
probably not activated (Fig. 4D). In addition, mTOR signaling
activity, a mechanism that has been considered to mediate IFN-
induced mRNA translation (28), remained unchanged over time,
also suggesting that the classical JAK-STAT mediated IFN sig-
naling pathway was inactive (Fig. 4D). Although increased con-
centrations of phosphorylated AKT and ERK1/2 were detected,
these factors play more general roles in metabolism, rather than
up-regulating type I and type II IFN responses. We also found no
evidence for either bacterial contamination or endotoxin in the
medium that might have triggered a type II IFN response, nor
were IFNG or IFNA/B detectable in the medium by immuno-
assay. Finally, FPKM values for IFNA subtypes and IFNB were
extremely low (Fig. 4A), while IFNG transcripts were undetect-
able. These data suggest that the up-regulation of IFN receptors
and downstream IFN response genes were not triggered by ex-
ogenous factors but were components of a constitutive devel-
opmental process associated with normal development.
About 8% of the human genome (29) consists of human en-
dogenous retroviruses (HERV) capable of producing virus-like
particles competent to induce an IFN response. The placenta
expresses several HERV that have been implicated in tropho-
blast differentiation and syncytialization (30, 31). Eight HERV
were expressed in cultured human embryos (Fig. 5A). Of these, 5
(ERV3-1, ERVFRD-1, ERVV-1, ERVV-2, and ERVW-1) were more
abundantly expressed in differentiated trophoblast cells (Pre-STB,
Pre-MTB, STB, and MTB) than in CTB. ERVV-1, ERV-2, and
ERVW-1 had the highest transcript levels, with the highest expres-
sion at D10 when the presence of ERVW-1 could be confirmed by
immunofluorescence (Fig. 5B). By contrast, expression of ERVH48-1
and ERVMER34-1 was higher in undifferentiated CTB than in



































Fig. 3. Dynamics of CTB differentiation. (A) PCA of trophoblast cells clustered by cell type and developmental stages. Data suggest that CTB cells are
considerably more dynamic than STB in different developmental stages. (B) Numbers of differentially expressed genes in CTB from different developmental
stages. (C) The number of cells in each cell type collected at different developmental stages. (D) Diagram to illustrate the switch of cell functions of CTB at
different developmental stages as revealed by GO terms and pathway analysis. (E) Diagram to illustrate the switch of cell functions of CTB as they undergo
differentiation to STB (Upper) and MTB (Lower) as revealed by GO terms and pathway analysis.
















































Fig. 4. IFN response pathways in early pregnancy. (A) FPKM values of the IFN-related genes: type I and type II IFN receptors (IFNAR1, IFNAR2, IFNGR1, and
IFNGR2), type I IFN (IFNA1 and IFNB1), and IFN-stimulated genes (ISG15 and ISG20). (B) Immunofluorescent localization of proteins implicated in potential IFN
responses in human embryos between D8 and D12 (n = 3). (Scale bar, 100 μm.) (C) Western blot analysis of IFNAR2 and ISG15 (n = 3) and (D) phosphorylation
of STAT1 (n = 3), mTOR (n = 3), AKT (n = 3), and MAPK1/3 (n = 3) in human embryos between D8 and D12. The expression of protein levels was normalized to
ACTB (actin beta). The ratio of phosphorylated (p) and total protein abundance was used to determine the phosphorylation level of target proteins. All data
are presented as the mean ± SEM.



































the more differentiated cell populations. ERVH48-1 is known to
inhibit rather than promote cell fusion, which it accomplishes by
competing with ERVW-1 for binding to its cell surface receptor
(32). ERVMER34-1 has barely been studied, but its presence in
CTB rather than STB suggests that it, too, might be an inhibitor
of cell fusion.
Discussion
Here we have employed an extended culture system for human
embryos, combined it with single-cell RNA-seq, and successfully
captured transcriptome dynamics in trophoblast cells occurring
within the primitive placenta between D8 and D12 postfertiliza-
tion, a time that in vivo corresponds to the first 5 d after the embryo
begins to implant into the uterine wall. It is important to note that
during this period, the familiar villous placenta, with its characteristic
thin outer syncytialized epithelium overlaying a mitotic population of
CTB stem cells has not yet emerged. Instead, the embryo proper is
surrounded by a mass of trophoblast, with STB and, as demonstrated
here, a population of migratory cells (here called MTB) toward the
exterior. Our data are consistent with the hypothesis that STB and
MTB are replenished from below by a progenitor population of
CTB. However, several facts should be born in mind about this early
placental structure. First, unlike villous STB (33), it has invasive/
migratory features that are probably responsible for its ability to
burrow into the endometrium and place the conceptus within a
hollowed-out niche where it can gain nutritional support from
close proximity with surrounding maternal decidual cells, capil-
laries, and glands. Second, the conceptus must produce sufficient
hCG and possibly other supporting factors to prevent a decline in
progesterone resulting from regression of the corpus luteum as
Fig. 5. Human endogenous retroviruses in peri-implantation embryos. (A) FPKM values (mean ± SEM) of several HERV in human embryos between D8 and
D12. (B) Immunofluorescence of ERVW-1 in D10 human embryos (n = 3). (Scale bar, 100 μm.)
















































would occur in a nonfertile cycle. Third, this early placenta, al-
though functional, is short lived. Columns of CTB begin to
penetrate the STB layer beginning around D12 and ultimately
give rise to the villous placenta while the fate of the initial STB
remains unclear. It is mistaken to believe, as others have done,
that the STB associated with the D8 to 12 placenta is equivalent
to villous STB, which it clearly is not, although it may have an
analogous function in supplying the embryo proper with nutrient
support. Additionally, the migratory cells (called MTB here)
should probably not be referred to as extravillous TB, since there
are no villous structures at this stage from which MTB could arise.
In terms of marker gene expression, the transcriptome profiles of
the MTB, including the expression of HLA-G, do appear to re-
semble those of first trimester EVT arising from the tips of an-
choring villi, but whether the latter are of the same lineage as
MTB is not clear.
At D8, when implantation in vivo would have just begun, the
majority of TB cells in the embryos were small and apparently
mitotically active and had a predominantly CTB phenotype, al-
though some STB and 1 or 2 Pre-STB and Pre-MTB cells were
also present in the CTB population (Fig. 3C) and were probably
responsible for the small amount of hCG produced at this time
(Fig. 1D). Trophectoderm, a simple epithelium, may provide the
progenitors for trophoblast outgrowth from cells at the polar end
of the blastocyst (24) but is clearly functionally distinct from
the trophoblast associated with implantation. Additionally, our
transcriptomic data reveal that the small cell population, while
appearing morphologically homogeneous, contained a subset of
mitotically active intermediate cytotrophoblast cells already tran-
scriptionally preparing either to fuse to form syncytium, particu-
larly apparent at D10, or to differentiate toward MTB (Figs. 2B
and 3C). This lineage bifurcation seemed to initiate around D8
but was most apparent at D10, when commitment to STB was at a
maximum and production of hCG was rising sharply (Figs. 1D and
3C). By D12, STB differentiation was in decline, but MTB pro-
duction was on the upswing (Fig. 3C). At D12, there was also an
indication of an upsurge in the proportion of undifferentiated,
mitotically active CTB (Fig. 3C), possibly reflecting the beginning
of villous formation and the demise of the early placenta. To-
gether these data suggest that the early placenta is distinct from
trophectoderm and, although short-lived, is able to prioritize highly
specialized cell functions at very specific time points throughout
the implantation period.
The transcriptomic data also provided some surprises. One
was the identification of several genes and GO pathways asso-
ciated with IFN signaling and partial activation of antiviral re-
sponses in the MTB. Although the production of type I and type
II IFN by trophoblast has been demonstrated in some ungulates
(34), and is especially important in ruminants where IFN-tau
(IFNT) plays a critical role in maternal recognition of preg-
nancy (35, 36), no homologous role for IFN was evident here for
the human, where neither type I nor type II IFN genes were
being transcribed (Fig. 4A). Rather, the MTB seemed poised to
respond to IFN, having both the receptors and some component
effectors already in place. Conceivably, IFN released by cells
resident in the endometrium would be able to trigger an IFN
response in trophoblast and provide some survival advantage to
the embryo in addition to serving as a first line of defense against
viral and bacterial infections. For example, in vitro fertilization
(IVF) patients with recurrent implantation failure have signifi-
cantly lower concentrations of intrauterine IFNG than controls
(37). Of course, overstimulation of IFN may desensitize IFN
pathways, a mechanism that contributes to unresponsiveness of
type I IFN in HIV disease (38). In human embryos, a high level
of IFN exposure as a result of uterine infection or inflammation
could lead to desensitization of IFN pathways and blockage of
trophoblast differentiation, resulting in embryo loss, thereby spar-
ing maternal costs associated with continuation of a blighted
pregnancy. Thus, IFN response pathways may act as a safety
switch that determines the success of implantation in vivo.
As anticipated, expression of transcripts for classical MHC
class I molecules, HLA-A and HLA-B (39), as well as MHC class
II molecules (40), illustrated here by HLA-DOB and HLA-DRB1
(SI Appendix, Fig. S9C), were poorly expressed in each class of
trophoblast cell at each developmental time point. By contrast,
HLA-C, and the nonclassical HLA-E, and HLA-G genes were
robustly expressed by D12 (SI Appendix, Fig. S9 A and B), es-
pecially in MTB. These human versions of the major histocom-
patibility complex (MHC) molecules have been proposed to be
responsible for creating an in vivo immunomodulatory environ-
ment that favors extravillous trophoblast invasion (41). Such fea-
tures of theMHC system, like the IFN signaling pathway discussed
previously, may be critical for early conceptus survival prior to
formation of the villous placenta at a perilous time in pregnancy
when embryonic wastage is high. A deeper investigation of these
transcriptomic data will likely elucidate additional insights into
mechanisms that facilitate human implantation.
It should be recognized that the embryos used in our exper-
iments were cultured in a medium in absence of maternal decidual
cells and on a substratum, namely, fibronectin, that would only be
a single component of the mixed matrix encountered in the en-
dometrium during implantation. For example, both substrate
composition and stiffness can influence transcriptomes of stem
cells (42, 43). Thus, the developmental trajectory observed here
in vitro might be somewhat different from that occurring in vivo in
a normal pregnancy. As demonstrated in Fig. 5, however, major
metabolism pathways remained active at D12, and there was an
apparent increase of mitotically active CTB and a rise of MTB.
Nonetheless, it would be overly optimistic to believe that the
embryos were not losing viability by this stage. As the technology
for extended embryo culture improves, it is likely that a system
more reflective of endometrium–conceptus interactions as they
occur in vivo will emerge. Therefore, even though the data pro-
vided in the present paper can only be an incomplete indication of
what goes on in vivo, we suspect that they still provide insight into
the functioning of the early placenta, a structure essential for
pregnancy maintenance prior to the time that the villous placenta
emerges. Our results are consistent with the inference that initial
implantation events and endocrine support of ovarian progester-
one production by the mother are a function of the STB sur-
rounding the conceptus as it invades, while the motile MTB is
responsible for initiating additional colonization of the uterine
endometrium prior to the outgrowth of placental villi.
Materials and Methods
Ethics Statement. This research was approved by the Western Institutional
Review Board (study no. 1179872) and followed international guidelines for
extended embryo culture. Embryos were donated for research with patients’
informed consent. Once a patient has completed treatment and has no
further medical need for their frozen embryos and no longer wants to retain
them, they have several options: discard and thus destroy their embryos,
donate their embryos to another couple for embryo adoption, or donate
them to research. This choice is certified by a signed and notarized dispo-
sition document. This process is completed by nonresearch personnel. Once a
patient has chosen and finalized “donation to research” and their decision
has been confirmed, those embryos become available for research.
Human Embryo Thawing and Zona Pellucida Removal. Human embryos (see SI
Appendix for further details) were voluntarily donated by patients at the
Colorado Center for Reproductive Medicine. D5 and D6 vitrified human
blastocysts were thawed in prewarmed solution for 1 min and transferred to
modified Kitazato dilution solution (Kitazato) for 3 min prior to washing
solution (WS) for 5 min (44). Individual blastocysts were placed in individual
culture drops of IVC1 medium (Cell Guidance Systems, M11 25) overlaid in
mineral oil and left for 2 h at 37 °C under 20% O2 and 7.5% CO2 to adjust for
the high elevation where these studies have been performed. After 2 h,
embryos were moved to 3-(N-morpholino)propanesulfonic acid (Mops)
buffered medium before removal of the zona pellucida by 3 sequential



































washes in Acidic Tyrode’s solution (Millipore Sigma, T1788) followed by 3
sequential washes in Mops.
Extended Embryo Culture. The extended embryo culture procedure was
performed as previously described (20, 21). Briefly, blastocysts immediately
after zona removal were washed in a 60-mm center-well organ culture dish
(Corning, 353037) containing warmed IVC1 medium before transfer into
8-well chamber dishes (Ibidi, 80841). Each chamber had been coated with
sterile fibronectin (Millipore Sigma, F0895) diluted in PBS at a 3:100 dilution.
Plates were coated overnight, and remaining soluble fibronectin were then
removed before addition of 300 μL equilibrated IVC1 medium. After at least
1 h, embryos lacking zonas were placed in the medium and cultured for a
further 48 h. On extended embryo culture day 2, embryo attachment was
assessed for all embryos. For embryos that had attached, half the IVC1
medium was removed and replaced with fresh IVC2 medium (Cell Guidance
Systems, M12-25). After day 2, a 50% media change with IVC2 media was
performed daily on all attached embryos.
Isolation of Single Cells. Single cells were isolated from embryos at embryonic
D8, D10, and D12; incubated with TrypLE Express reagent for 10 min; and
dissociated into single cells. For D12 embryos, migratory TB (MTB) that were
located outside the main colony were collected before the main colony had
been dissociated. After gentle pipetting, rounded, single mononucleated
cytoTB (CTB) and multinucleated syncytioTB (STB) were collected. Each cell
was transferred into a 0.2-mL PCR tube (Eppendorf) containing cell lysis
buffer and kept at −80 °C until library preparation.
Single-Cell RNA-Seq Library Preparation. The RNA-seq libraries were gener-
ated from individual cells by using the Smart-seq2 v4 kit with minor modi-
fication from manufacturer’s instructions. Briefly, individual cells were
lysed, and mRNA was captured and amplified with the Smart-seq2 v4 kit
(Clontech). After AMPure XP beads purification, amplified RNAs were
quality checked by using Agilent High Sensitivity D5000 kit (Agilent Tech-
nologies). High-quality amplified RNAs were subject to library preparation
(Nextera XT DNA Library Preparation Kit; Illumina) and multiplexed by
Nextera XT Indexes (Illumina). The concentration of sequencing libraries was
determined by using Qubit dsDNA HS Assay Kit (Life Technologies) and
KAPA Library Quantification Kits (KAPA Biosystems). The size of sequencing
libraries was determined by means of High Sensitivity D5000 Assay in at
Tapestation 4200 system (Agilent). Pooled indexed libraries were then se-
quenced on the Illumina HiSeq X platform with 100-bp pair-end reads.
Single-Cell RNA-Seq Data Filtration and Processing. Multiplexed sequencing
reads that passed filters were trimmed to remove low-quality reads and
adaptors by TrimGalore-0.4.3. The quality of reads after filtering was assessed
by fastQC, followed by alignment to the human genome (hg38) by STAR
(2.5.3a) with default parameters. Approximately 10 million reads per indi-
vidual cell were generated. Individual mapped reads were adjusted to pro-
vide FPKM (fragments per kilobase of exon model per million mapped
fragments) values with RefSeq genes as reference. The raw FASTQ files and
normalized gene expression profiles (FPKM) are available at Gene Expression
Omnibus (GEO) (https://www.ncbi.nlm.nih.gov/geo/) under the accession
number GSE 130289. Differential gene expression analysis was performed
by a Partek Flow GSA algorithm with default parameters. The genes were
deemed differentially expressed if they provided a false discovery rate
of <0.05 and fold change >2. DAVID (https://david.ncifcrf.gov) and IPA (In-
genuity Pathway Analysis) were used to reveal the Gene Ontology (GO) and
pathways, respectively. Cells with more than 8,000 detected genes, each
with FPKM values >0.3, were used for downstream analysis for lineage
specification. Lineage specification was performed by Spearman correlation.
PCA and cluster analysis were performed by using R. Identification of cell
type and stage-specific genes was performed as previously described (45).
Briefly, to identify cell type and stage-specific genes, a unit vector was
constructed for each cell type (stage), followed by the calculation of the
Pearson correlation between the vector and individual genes. This unit
vector was designed to represent cell type (stage)-specific gene expression
patterns. More specifically, the entries of the vector corresponding to sam-
ples of a cell type (or at a stage) were set to 1, with all others being 0. Genes
with P value (after Bonferroni correction for multiple testing) less than 0.05
were labeled as cell type (stage) specific.
Immunofluorescence and Image Acquisition. Embryos were washed 3 times in
warmed, filtered PBS and fixed in 4% paraformaldehyde (PFA) for 20 min.
They were then washed in 0.1% Tween20 (Millipore Sigma, P1379) in PBS
(PBS-T) 3 times and permeabilized by 0.5% Triton X-100 (Millipore Sigma,
X100) in PBS for 30 min. Embryos were washed again in PBS-T and exposed to
10% vol/vol FBS and 3% wt/vol BSA in PBS-T overnight at 4 °C. Primary an-
tibodies (SI Appendix, Table S4) were added at a 1:200 dilution in blocking
buffer (10% FBS/3% BSA/PBS-T) and incubated at 4 °C overnight. Samples
were then washed in PBS-T 3 times and incubated with secondary antibodies
overnight at 4 °C. After incubation, embryos were washed again in PBS-T
and then mounted in ProLong Gold antifade reagent with DAPI (Thermo-
Fisher Scientific, P36931) mounting medium. Embryos were imaged on a 3I
Marianas inverted spinning disk microscope. Z-stack images were captured
by using a 40x/1.52 numerical aperture oil-immersion objective. The lasers
405, 488, and 561 were used to capture DAPI, Alexa Fluor 488, and Alexa
Fluor 594, respectively. Laser intensity and exposure time was manually
adjusted for each sample to avoid oversaturation or photobleaching of
samples. After image capture, images were immediately deconvoluted by
means of Slidebook software (3i) set to the “Nearest Neighbors” setting.
Images were rendered and processed with Imaris microscopy image analysis
software (Bitplane) to generate maximum intensity projections.
Other methods including Western blotting, ELISA and ECLIA analyses, and
statistical analysis are summarized in SI Appendix. Antibodies used for
immunofluorescence and Western blotting are listed in SI Appendix, Tables
S4 and S5.
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